Nvidia and Eli Lilly will invest up to $1 billion to open an AI co-innovation lab in the Bay Area, with work expected to begin in South San Francisco early this year. The facility pairs Nvidia compute with Lilly data to accelerate drug discovery.

OpenAI acquired Torch, a health data startup, to improve ChatGPT Health, potentially changing how people access and interact with their medical information.

Common Sense Media and OpenAI support the new Parents & Kids Safe AI Act to improve online safety for children, particularly focusing on AI chatbot regulation. The act proposes independent safety audits and holds companies accountable.

UCSF has joined a Phase 3 trial testing MM120, an LSD tablet, as a possible one‑time treatment for generalized anxiety disorder after promising midstage results.

Palo Alto plans a March pilot of expanded city-run fiber while critics warn the project faces steep competition and financial risks.

A 9th Circuit panel pushed back on Meta’s bid to dismiss hundreds of youth‑addiction lawsuits, raising new questions about Section 230 and platform design.

Palo Alto Networks is reportedly negotiating a roughly $400M purchase of Israeli startup Koi, which builds a supply‑chain gateway for endpoints. Talks are said to include a preliminary MOU.

Tesla's sales fell by 9% in 2025 to 1.64 million vehicles, losing its spot as the world's largest EV seller to BYD's 2.26 million. Factors include loss of a $7,500 tax credit, Musk's politics, and strong competition.

San Francisco Business Times found the Bay Area’s largest year‑end stock sale was about $4 billion in biotech, as local drug developers leaned on secondary offerings to raise cash. Terns was among the biggest raises in December.

One of Elon Musk's attorneys signs discovery briefs by day and runs Clown Cardio classes in LA by night. His dual life has crept into the Musk v. Altman discovery fight.

OpenAI is seeking a Head of Preparedness to tackle AI risks, a role requiring technical expertise and immediate immersion into complex safety challenges.

A Deep Origin‑led consortium won up to $31.7M from ARPA‑H; La Jolla’s Sanford Burnham Prebys will help build AI and tissue models to predict toxicity and speed drug development.

A provocative billboard campaign and a brazen website called Replacement.AI have landed on San Francisco streets — and people are asking whether it’s art, a stunt, or a warning.